Skip to: content – navigation

2017 Scientific Program

Submitted by Jennifer Burges... on Mon, 05/15/2017 - 18:09

2017 Scientific Program

Resources of the event: 

Effective Interaction with the Government Regarding Cancer Drug Access_The Hon John Brumby AO

Cancer Drugs Alliance (CDA) involvement_Prof John Zalcberg OAM

Clinical Benefit Parameters (ASCO, ESMO)_Prof Andrew Wilson

TGA Reform_Dr Larry Kelly

Premium Sponsor Address_Ms Tracey Padman, Roche Products

Premium Sponsor Address_Dr Ian Irving, Icon Cancer Care

Status of Oncology Clinical Committee/Taskforce Review_A/Prof Mustafa Khasraw

Potential Impact of MBS Review for Private Oncology_Dr Ian Irving

Lobby activities by PCPA/Stakeholder Group_Ms Jannette Cotterell

Appropriate Prescribing of Chemotherapy - the Role of eviQ Guidelines_A/Prof Jeremy Shapiro

Chaired Panel Discussion: A/Prof Chris Karapetis, A/Prof Jeremy Shapiro and Dr Owen Bradfield

read more
read more
An election manifesto on
behalf of Australian cancer patients and their families
The ‘Cancer Care, No Gaps’ Journey. Clinical trials – more patients, less cost.
download pdf
Join the PCPA
Enjoy all the benefits of membership
With a strong leadership group and a potential membership base of all private oncologists and haematologists, PCPA represents a critical group of specialists in the cancer care service spectrum.
join PCPA
Latest Media Release
May 9, 2019
Private oncologists reject PM claims of ‘fee hikes’ for cancer patients
read more